Home
Interesting shortcuts
Projects
Projects
Resources
Resources
Programmes and Partnerships
Search
EU-Programme-Call
European Partnerships
www.decubber.com
Login
Project
AMPK-DIAB
Organisations
A small molecule AMP activated protein kinase (AMPK) activator, denoted O304, as a novel innovative drug for the treatment of type 2 diabetes
Full project page
Organisations map overview
BETAGENON AB
- (Coördinator)
Country: